1784 related articles for article (PubMed ID: 16168832)
21. Dose-painting intensity-modulated proton therapy for intermediate- and high-risk meningioma.
Madani I; Lomax AJ; Albertini F; Trnková P; Weber DC
Radiat Oncol; 2015 Mar; 10():72. PubMed ID: 25890217
[TBL] [Abstract][Full Text] [Related]
22. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
Cozzi L; Fogliata A; Lomax A; Bolsi A
Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
[TBL] [Abstract][Full Text] [Related]
23. Impact of IMRT and leaf width on stereotactic body radiotherapy of liver and lung lesions.
Dvorak P; Georg D; Bogner J; Kroupa B; Dieckmann K; Pötter R
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1572-81. PubMed ID: 15817364
[TBL] [Abstract][Full Text] [Related]
24. A treatment planning inter-comparison of proton and intensity modulated photon radiotherapy.
Lomax AJ; Bortfeld T; Goitein G; Debus J; Dykstra C; Tercier PA; Coucke PA; Mirimanoff RO
Radiother Oncol; 1999 Jun; 51(3):257-71. PubMed ID: 10435821
[TBL] [Abstract][Full Text] [Related]
25. Impact of grid size on uniform scanning and IMPT plans in XiO treatment planning system for brain cancer.
Rana S; Zheng Y
J Appl Clin Med Phys; 2015 Sep; 16(5):447–456. PubMed ID: 26699310
[TBL] [Abstract][Full Text] [Related]
26. Assessment of improved organ at risk sparing for meningioma: light ion beam therapy as boost versus sole treatment option.
Mock U; Georg D; Sölkner L; Suppan C; Vatnitsky SM; Flechl B; Mayer R; Dieckmann K; Knäusl B
Radiother Oncol; 2014 Jun; 111(3):451-6. PubMed ID: 25012644
[TBL] [Abstract][Full Text] [Related]
27. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
28. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer.
Seco J; Gu G; Marcelos T; Kooy H; Willers H
Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):188-94. PubMed ID: 23920395
[TBL] [Abstract][Full Text] [Related]
29. Results of a multicentric in silico clinical trial (ROCOCO): comparing radiotherapy with photons and protons for non-small cell lung cancer.
Roelofs E; Engelsman M; Rasch C; Persoon L; Qamhiyeh S; de Ruysscher D; Verhaegen F; Pijls-Johannesma M; Lambin P;
J Thorac Oncol; 2012 Jan; 7(1):165-76. PubMed ID: 22071782
[TBL] [Abstract][Full Text] [Related]
30. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
31. Intensity modulated photon and proton therapy for the treatment of head and neck tumors.
Steneker M; Lomax A; Schneider U
Radiother Oncol; 2006 Aug; 80(2):263-7. PubMed ID: 16916557
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic radiotherapy for choroidal melanomas by means of HybridArc™ : Physics and technique of linac-based photon beam therapy.
Wösle M; Krause L; Sreenivasa S; Vordermark D; Ciernik IF
Strahlenther Onkol; 2018 Oct; 194(10):929-943. PubMed ID: 30116827
[TBL] [Abstract][Full Text] [Related]
33. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
[TBL] [Abstract][Full Text] [Related]
34. Use of single-energy proton pencil beam scanning Bragg peak for intensity-modulated proton therapy FLASH treatment planning in liver-hypofractionated radiation therapy.
Wei S; Lin H; Shi C; Xiong W; Chen CC; Huang S; Press RH; Hasan S; Chhabra AM; Choi JI; Simone CB; Kang M
Med Phys; 2022 Oct; 49(10):6560-6574. PubMed ID: 35929404
[TBL] [Abstract][Full Text] [Related]
35. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma.
Mock U; Georg D; Bogner J; Auberger T; Pötter R
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):147-54. PubMed ID: 14697432
[TBL] [Abstract][Full Text] [Related]
36. Dosimetric study using different leaf-width MLCs for treatment planning of dynamic conformal arcs and intensity-modulated radiosurgery.
Jin JY; Yin FF; Ryu S; Ajlouni M; Kim JH
Med Phys; 2005 Feb; 32(2):405-11. PubMed ID: 15789586
[TBL] [Abstract][Full Text] [Related]
37. Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma.
Kung SW; Wu VW; Kam MK; Leung SF; Yu BK; Ngai DY; Wong SC; Chan AT
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):71-9. PubMed ID: 20385452
[TBL] [Abstract][Full Text] [Related]
38. Comparison of intensity modulated radiation therapy (IMRT) treatment techniques for nasopharyngeal carcinoma.
Cheng JC; Chao KS; Low D
Int J Cancer; 2001 Apr; 96(2):126-31. PubMed ID: 11291096
[TBL] [Abstract][Full Text] [Related]
39. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
[TBL] [Abstract][Full Text] [Related]
40. Comparing photon and proton-based hypofractioned SBRT for prostate cancer accounting for robustness and realistic treatment deliverability.
Goddard LC; Brodin NP; Bodner WR; Garg MK; Tomé WA
Br J Radiol; 2018 May; 91(1085):20180010. PubMed ID: 29436852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
